Tianjin Medical University is the lead sponsor of 26 current clinical trials in our China register. 22 are recruiting patients now. The most common phase is Observational. The drugs named most often in its trials are Baloxavir Marboxil and Upadacitinib. The most-studied condition is Positron Emission Tomography.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Beta Amyloid PET/CT in Various Aβ-Related Disease
NCT06725706 · ClinicalTrials.gov ↗ · Amyloid, Beta-Amyloid, Neurodegenerative Diseases
|
Observational | Recruiting | 2012-09 | China |
|
Translocator Protein PET/CT in Various TSPO-Related Disease
NCT06725719 · ClinicalTrials.gov ↗ · Neuroinflammation, Stroke, Neurodegenerative Diseases
|
Observational | Recruiting | 2018-11 | China |
|
Amino Acid Transporter System PET/CT Imaging in AATS-Related Diseases
NCT07379463 · ClinicalTrials.gov ↗ · Amino-Acid Transport Disorder, Primary Hyperparathyroidism, Glioma
|
Observational | Recruiting | 2013-08 | China |
|
Somatostatin Receptor PET/CT in SSTR-Related Disease Patients
NCT06690957 · ClinicalTrials.gov ↗ · SSTR-related Disease, Tumor, Positron Emission Tomography
|
Observational | Recruiting | 2019-02 | China |
|
Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients
NCT06690970 · ClinicalTrials.gov ↗ · PSMA-related Disease, Prostate Cancer, Positron Emission Tomography
|
Observational | Recruiting | 2020-09 | China |
|
Pan-Amyloid PET/CT in Various Amyloid-Related Disease
NCT07130565 · ClinicalTrials.gov ↗ · Amyloid, Cardiac Amyloidosis, Amyloidosis
|
Observational | Recruiting | 2023-11 | China |
|
[18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis
NCT07232459 · ClinicalTrials.gov ↗ · Amyloid, Cardiac Amyloidosis, Amyloidosis
|
Observational | Recruiting | 2025-07 | China |
|
Alpha-Synuclein PET/CT in Various α-Syn-Related Disease
NCT06949670 · ClinicalTrials.gov ↗ · Alpha Synuclein Pathology, Alpha-Synuclein, Parkinson Disease
|
Observational | Recruiting | 2025-04 | China |
|
Programmed Cell Death Ligand 1 PET/CT in Various PD-L1-Related Disease Patients
NCT07618936 · ClinicalTrials.gov ↗ · PD-L1 Gene Mutation, PD-L1 Gene Amplification, PD-L1-related Disease
|
Observational | Recruiting | 2026-06 | China |
|
Monoamine Oxidase A PET/CT in Various MAO-A-Related Disease
NCT07685860 · ClinicalTrials.gov ↗ · Depression, Anxiety, Heart Injuries
|
Observational | Recruiting | 2026-06 | China |
|
Chemokine Receptor 4 PET/CT Imaging of CXCR4-Related Diseases
NCT06690736 · ClinicalTrials.gov ↗ · CXCR4-related Disease, Tumor, Positron Emission Tomography
|
Not applicable | Recruiting | 2022-03 | China |
|
A Study of YUTIQ® 0.18 mg Intravitreal Implant for the Management of Chronic Non-infectious Uveitis
NCT05592717 · ClinicalTrials.gov ↗ · Uveitis, YUTIQ
|
Observational | Recruiting | 2023-01 | China |
|
Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis
NCT05911503 · ClinicalTrials.gov ↗ · Cytomegalovirus Retinitis, Ganciclovir Eye Drops
|
Phase EARLY_PHASE1 | Recruiting | 2023-07 | China |
|
Tau PET/CT in Various Tau-Related Disease Patients
NCT06690983 · ClinicalTrials.gov ↗ · Tauopathies, Neurodegenerative Diseases, Neurodegeneration
|
Observational | Recruiting | 2018-08 | China |
|
FAPI PET/CT in Various FAP-Related Disease Patients
NCT06688071 · ClinicalTrials.gov ↗ · FAP-related Disease, Tumor, Positron Emission Tomography
|
Observational | Recruiting | 2022-03 | China |
|
Hydroxyephedrine PET/CT in Sympathetic Nervous System Disease
NCT06951984 · ClinicalTrials.gov ↗ · Sympathetic Nervous System Diseases, Sympathetic Nervous Structure Injury, Sympathetic Nerve Injury
|
Observational | Recruiting | 2013-03 | China |
|
SNRK & Vascular Endothelial Aging
NCT07591337 · ClinicalTrials.gov ↗ · Vascular Aging
|
Observational | Recruiting | 2026-05 | China |
|
[18F]NIDF PET Imaging in Tau-related Diseases
NCT07306598 · ClinicalTrials.gov ↗ · Neurodegenerative Disease, Alzheimer s Disease, Tauopathies
|
Observational | Recruiting | 2025-11 | China |
|
ALI & Pulmonary HA Deposition After SAH
NCT06628531 · ClinicalTrials.gov ↗ · Subarachnoid Haemorrhage (SAH)
|
Observational | Recruiting | 2024-12 | China |
|
Monoamine Oxidase B PET/CT in Various MAO-B-Related Disease
NCT07685873 · ClinicalTrials.gov ↗ · Parkinson Disease, Parkinson Disease Dementia, Parkinson's Disease and Parkinsonism
|
Observational | Recruiting | 2026-06 | China |
|
Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease
NCT06725693 · ClinicalTrials.gov ↗ · GLP1-R-related Disease, Tumor, Insulinoma
|
Observational | Recruiting | 2019-02 | China |
|
Glycoprotein IIb/IIIa PET/CT in Various GPIIb/IIIa-Related Disease
NCT07813559 · ClinicalTrials.gov ↗ · Thrombi, Thrombus, Brain, Thrombus
|
Observational | Recruiting | 2026-09 | China |
|
Effectiveness of Xuanfei Jiangzhuo Decoction for Influenza-Induced AECOPD
NCT07393685 · ClinicalTrials.gov ↗ · Acute Exacerbation of Chronic Obstructive Pulmonary Disease, Influenza, Human, Virus Diseases
Drug: Baloxavir Marboxil |
Observational | Not yet open | 2026-08 | China |
|
FuKe Qianjin Capsule Plus Antibiotics for Chronic Endometritis
NCT07485842 · ClinicalTrials.gov ↗ · Chronic Endometritis
|
Phase 4 | Not yet open | 2026-04 | China |
|
Displacement of Iodine Balance Value During Pregnancy and the Mechanism of Breast Iodine Homeostasis During Lactation
NCT05730803 · ClinicalTrials.gov ↗ · Nutritional Requirements
|
Observational | Not yet open | 2023-02 | China |
|
An Interventional Study of Upadacitinib Extended-Release Tablets in Patients With Refractory Uveitis
NCT07773623 · ClinicalTrials.gov ↗ · Uveitis
Drug: Upadacitinib |
Phase 4 | Active, closed | 2025-01 | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 26 | 22 |
A trial with sites in more than one country appears in each of those registers.
Tianjin Medical University is the lead sponsor of 26 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 22 of its 26 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Its current trials name 2 drugs and biologicals as interventions. The most frequent are Baloxavir Marboxil (1) and Upadacitinib (1). The number in brackets is how many of its trials name each drug.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.